U.S. inflation increased to 8.5% in March from its previous level over the past twelve months, which is the highest it has been in four decades. The rise in prices was primarily driven by increases in energy and food costs,… Continue Reading  

Inflation rose to a 7.9% annual rate in February. It’s the highest it’s been in 40 years. Higher prices for energy, groceries and eating out at restaurants helped push up that inflationary reading. Economists also expect further price increases associated… Continue Reading  

Although the Ambassador Bridge is now open, the recent closure of the bridge has received international attention. And rightfully so. The Ambassador Bridge accounts for approximately 25% of all trade between Canada and the United States, and it is a… Continue Reading  

Recently, the International Monetary Fund (IMF) released its preliminary findings regarding its economic outlook for the U.S.1 The IMF notes that the unprecedented fiscal and monetary support, combined with the receding COVID-19 case numbers, should provide a substantial boost to… Continue Reading  

The Office of Inspector General (“OIG”) recently conducted an audit of the recall processes of the National Highway Traffic Safety Administration’s (“NHTSA”) Office of Defects Investigation (“ODI”) and found that NHTSA did not adequately manage light passenger vehicle recalls. The… Continue Reading  

A litigator can hire a skilled economic damages’ expert, but if that expert cannot concisely convey complex, financial topics in a succinct fashion to a judge or jury, then the litigator may win on liability for the client but may… Continue Reading  

By Dr. Andrew Malec and Susan Koss, Managing Directors at O’Keefe As is the case with most complex commercial litigation matters, patent holders must first prove causality before economic damages are considered. However, patent infringement cases are unique when compared with… Continue Reading  

In the ongoing battle to keep generic drugs off the market, Cephalon, Inc. filed suit against Dr. Reddy Laboratories, Ltd. (“DRL”) claiming patent infringement on its TREANDA patent arising from DRL’s filing of an Abbreviated New Drug Application (“ANDA”) to… Continue Reading  

Section 34 of the Leahy-Smith America Invents Act (“AIA”) mandated that the United States Government Accountability Office (“GAO”) conduct a study on the consequences of patent litigation by nonpracticing entities (NPEs).  As such, the GAO’s objectives were to determine (1)… Continue Reading  

Innovation is central to economic growth, and the United States still ranks high globally on a number of important measures of innovative capacities. A recent report from the Metropolitan Policy Program at Brookings studied the current state of invention in… Continue Reading